Diabetes management software from Tandem gets FDA OK

02/28/2013 | San Diego Business Journal

The FDA has cleared Tandem Diabetes Care to market its t:connect diabetes management software. The technology, set to be released next month, provides diabetes patients and their doctors with electronic access to information from the company's t:slim insulin delivery systems and blood glucose monitors.

View Full Article in:

San Diego Business Journal

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC